Every investigation we've published, newest first — each one built on primary documents and classified under our evidence standard.
Evolv's scanners are used to screen more than 700,000 children and school visitors daily. The FTC says the company's claims about detecting weapons and ignoring harmless objects were misleading.
Read the full report →The FTC examined IQVIA's business of collecting and selling patient-level prescription data to pharmaceutical companies and other buyers, questioning whether the company's privacy protections were sufficient given the sensitivity of the health information being commercialized and the limited role patients played in authorizing those data flows.
Read the full report →A DEA and DOJ investigation found that Sievert Physical Therapy participated in an opioid referral arrangement in which the clinic received payments tied to patient referrals for controlled substance prescriptions from connected prescribers.
Read the full report →The DOJ found Tri-Med Associates had enrolled patients in Medicare hospice care who did not meet the terminal prognosis requirement for hospice eligibility — billing Medicare for hospice services for patients who were not terminally ill and, in some cases, for patients who received minimal or no actual hospice services.
Read the full report →The SEC investigated Sarepta Therapeutics over whether public statements about clinical trial results for its Duchenne muscular dystrophy gene therapy program accurately characterized the data and its evidentiary strength, examining whether investor disclosures were materially consistent with the clinical evidence the company's own scientists had documented.
Read the full report →Seek Capital advertised itself as the market leader in small-business loans. The FTC alleges what business owners actually got, after paying thousands of dollars, was credit card accounts opened in their name.
Read the full report →The FTC and FDA jointly warned Vitacost.com that product descriptions on its supplement retail pages contained disease treatment and prevention claims that federal law does not permit dietary supplements to make without approved drug status.
Read the full report →The DOJ and EPA found Stericycle had accepted regulated pharmaceutical and hazardous waste from healthcare clients and disposed of it at treatment facilities not permitted for those waste streams — a systematic violation of environmental law that affected facilities across the company's national network and resulted in a major consent decree.
Read the full report →The FTC charged Envita Medical Center with advertising false survival rates and curative outcomes for its integrative cancer treatment programs to terminal patients, finding the claims were not supported by clinical evidence and that the testimonials used in its marketing were materially misleading.
Read the full report →The SEC charged Intellicheck Inc. and its former CEO with misleading investors about the company's revenue pipeline and customer relationships in public filings and earnings calls.
Read the full report →Consumers were threatened with arrest and wage garnishment over debts the FTC says GCI had no legal right to collect — some of which may not have existed at all.
Read the full report →Horizon Benefits Group recommended health insurance carriers to employers sponsoring group health plans without disclosing that those carriers paid the brokerage materially higher compensation than alternatives — a conflict that federal law requires brokers to disclose before employers can meaningfully evaluate their recommendations.
Read the full report →